Dr. Salameh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Harbor-UCLA Medical Center
1000 W carson Street
Torrance, CA 90509Phone+1 424-306-4532Fax+1 657-213-2664- Is this information wrong?
Summary
- Dr. Wael Salameh is Visiting Professor of Medicine at David Geffen School off Medicine At UCLA. He received his medical degree from Iuliu Hatieganu University of Medicine and Pharmacy and has been in either Academic Medicine or Biotech/ Pharma for 35 years. He also speaks multiple languages, including Arabic, French, Romanian, and Spanish. He is trained in Endocrinology, Diabetes and Metabolism and is experienced in Andrology and laboratory medicine. He is currently faculty at the department of General Internal Medicine and director of the continuity care clinic at Harbor-UCLA Medical Ctr.
Clinical Expertise
- Diabetes mellitus, Growth hormone deficiency, Health technology/informatics, Andrology , Laboratory medicine
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
University of Maryland Capital Region HealthResidency, Internal Medicine, 1984 - 1987
University of MarylandInternship, Surgery, 1983 - 1984
Iuliu Hatieganu University of Medicine and PharmacyClass of 1982
Certifications & Licensure
CA State Medical License 1988 - 2025
PA State Medical License 1990 - 1996- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- New Faculty Award Research and Education Institute ( currently Labiomed), 1998-2000
- President House Staff Association Prince George Medical Center, 1985-1986
Clinical Trials
- Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men Start of enrollment: 2011 Jul 01
- Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men Start of enrollment: 2012 Aug 01
- Safety and Efficacy Trial of Testosterone Undecanoate Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 97 citationsDihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels.Ronald S. Swerdloff, Robert E Dudley, Stephanie T. Page, Christina Wang, Wael A. Salameh> ;Endocrine Reviews. 2017 Jun 1
- 112 citationsSpecificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Instit...Wael A. Salameh, Mildred M. Redor-Goldman, Nigel J. Clarke, Ruchi Mathur, Ricardo Azziz, Richard E. Reitz> ;Fertility and Sterility. 2014 Apr 1
- 15 citationsNovel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients.Nazanin Noori, Michael P. Caulfield, Wael A. Salameh, Richard E. Reitz, Susanne B. Nicholas, Miklos Z. Molnar, Allen R. Nissenson, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh> ;Clinical Journal of the American Society of Nephrology. 2011 Dec 1
- Join now to see all
Grant Support
- Hu-Ime1 Characterization And MALE InfertilityEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–1999
- Hu-Ime1 Characterization And MALE InfertilityEunice Kennedy Shriver National Institute Of Child Health &Human Development1995
Professional Memberships
- Member
Other Languages
- Arabic, French, Romanian, Spanish
Hospital Affiliations
Harbor-UCLA Medical CenterTorrance, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
